cancer vaccines Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial The companies will use Personalis' ImmunoID Next technology to analyze patient response to a combination of Evaxion's EVX-01 with the immunotherapy Keytruda. BostonGene Collaborates With Transgene, NEC Corporation on Trials of Bespoke Cancer Vaccine The firm will conduct genomic and transcriptomic analysis to identify predictors of response to the personalized immunotherapy TG4050. Gallbladder Cancer Vaccine Candidate Identified Through Genomic Analysis Researchers from MedGenome, Genentech, and multiple international institutions found potentially actionable alterations in more than 200 gallbladder cancer samples. BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said. The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications Premium GenomeWeb asked a number of prominent researchers in the field via email about their top picks for notable developments or achievements in genomics during the 2010s. Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.